Search
for
Sort by
Research 241–270 of 1000+
- Understanding the Association Between Mental Health and Hair Loss
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Group IID, IIE, IIF and III secreted phospholipase A2s
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- 1317 Nicotinic acid suppresses sebaceous lipid synthesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA2)
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Epidemiology and burden of alopecia areata: a systematic review
- Multiple minute digitate hyperkeratosis
- Primary cicatricial alopecias
- Exploring the association between alopecia areata and thyroid dysfunction: A review
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IGG AND IGA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- COVID-19 infection leading to acute pustular dermatoses
- Oxidative stress and alopecia areata
- Increase in IL-15 levels in patients with alopecia areata
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- The role of janus kinases in the treatment of autoimmune skin diseases
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- The Potential Application of Exosomes as Therapeutic Agents, Carriers, and Biomarkers in Skin Diseases
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context